Related Experiment Videos
Benign Share Benefit to Malignant: Balanced Mixing on Feature Space for Imbalanced Breast Cancer Classification
Farchan Hakim Raswa1, Muhammad Fadlurrohman1,2, Bach-Tung Pham1
1Department of Computer Science and Information Engineering, National Central University, Taoyuan 320317, Taiwan.
Bioengineering (Basel, Switzerland)
|July 28, 2026
Summary
The B2M framework improves deep learning for mammography by addressing imbalanced datasets, enhancing the detection of rare malignant categories in C-View mammograms.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Machine Learning
Background:
- Imbalanced mammography datasets can bias deep learning models, leading to under-recognition of less frequent malignant or high-risk categories.
- Accurate classification of Breast Imaging Reporting and Data System (BI-RADS) categories is crucial for effective breast cancer diagnosis.
Purpose of the Study:
- To propose B2M (Benign Share Benefit to Malignant), a model-agnostic framework to address imbalance-aware multi-class BI-RADS classification in C-View mammography.
- To improve the recognition of less frequent malignant and high-risk BI-RADS categories within imbalanced datasets.
Main Methods:
- B2M employs a two-phase training strategy combining dual sampling (instance-based and class-balanced) with feature-space mixing.
- Phase I trains the model with dual sampling to balance class representation while preserving diversity.
- Phase II fine-tunes the model using feature-space mixing and a soft-target regularization objective for smoother decision boundaries.
Main Results:
- B2M was evaluated on an imbalanced C-View mammography cohort (EMBED dataset) using stratified 5-fold cross-validation.
- The ResNeXt-50 model integrated with B2M achieved superior balanced accuracy and Macro-F1 scores compared to other oversampling and mixing methods.
- While B2M introduces an approximate 2.81× offline training overhead, it does not increase inference costs.
Conclusions:
- B2M demonstrates potential as an effective framework for imbalanced multi-class BI-RADS classification in C-View mammography.
- Further external and prospective validation is necessary before widespread clinical adoption.